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Abstract
Background: Appropriate screening may reduce the mortality and morbidity of colorectal, breast, and cervical
cancers. Several high-quality systematic reviews and practice guidelines exist to inform the most effective screening
options. However, effective implementation strategies are warranted if the full benefits of screening are to be
realized. We developed an implementation guideline to answer the question: What interventions have been shown
to increase the uptake of cancer screening by individuals, specifically for breast, cervical, and colorectal cancers?
Methods: A guideline panel was established as part of Cancer Care Ontario’s Program in Evidence-based Care, and
a systematic review of the published literature was conducted. It yielded three foundational systematic reviews and
an existing guidance document. We conducted updates of these reviews and searched the literature published
between 2004 and 2010. A draft guideline was written that went through two rounds of review. Revisions were
made resulting in a final set of guideline recommendations.
Results: Sixty-six new studies reflecting 74 comparisons met eligibility criteria. They were generally of poor to
moderate quality. Using these and the foundational documents, the panel developed a draft guideline. The draft
report was well received in the two rounds of review with mean quality scores above four (on a five-point scale)
for each of the items. For most of the interventions considered, there was insufficient evidence to support or
refute their effectiveness. However, client reminders, reduction of structural barriers, and provision of provider
assessment and feedback were recommended interventions to increase screening for at least two of three cancer
sites studied. The final guidelines also provide advice on how the recommendations can be used and future areas
for research.
Conclusion: Using established guideline development methodologies and the AGREE II as our methodological
frameworks, we developed an implementation guideline to advise on interventions to increase the rate of breast,
cervical and colorectal cancer screening. While advancements have been made in these areas of implementation
science, more investigations are warranted.
Introduction
Cancer screening has the capacity to reduce morbidity
and mortality from disease [1]. Several international,
national, and regional guidelines exist that provide
recommendations on which screening manoeuvres are
most effective, efficient, and safe, and for which patients
or members of the public [2-4]. However, for screening
activities to yield benefits, they must be applied. Thus,
identification of effective interventions designed to
increase screening rates are needed. The Cancer Screen-
ing Uptake Expert Panel in partnership with the practice
guidelines program of the Ontario cancer system, Can-
cer Care Ontario’s Program in Evidence-based Care,
came together to develop an implementation guideline
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increase the uptake of screening for breast, cervical, and
colorectal cancers (CRCs). Our guidance is intended for
healthcare providers, system leaders, and organizations
responsible for implementing cancer screening programs
and members of the public.
The specific guideline question we asked was: What
interventions have been shown to increase the uptake of
cancer screening by individuals, specifically for breast,
cervical, and CRCs?
Interventions of interest include:
1. Population-based interventions aimed to increase
the demand for cancer screening, including client
reminders, client incentives, mass media, small media,
group education, and one-on-one education.
2. Population-based interventions aimed to reduce
barriers to obtaining screening, including reduction in
structural barriers and reduction in out-of-pocket costs.
3. Provider-directed interventions targeted at clinicians
to implement in the primary care setting, including pro-
vider assessment and feedback interventions and provi-
der incentives.
Our outcome of interest was completed screening
rates.
Methods
Cancer Care Ontario’s Program in Evidence-based Care
and Provincial Screening Program established the Can-
cer Screening Uptake Panel to complete the guideline
project (see Additional file 1: Appendix). The multidisci-
plinary panel was comprised of primary care providers,
researchers, managers of screening programs, experts in
implementation science, systematic review, and practice
guideline development, and methodologists. Patients
with cancers or citizens were not recruited to be on the
panel. All panel members disclosed conflicts of interest.
No conflicts were identified.
The guideline development cycle [5,6] and the AGREE
II framework [7-9] were used as the methodological
foundations for this project. The Cancer Screening
Uptake Expert Panel conducted an initial scoping review
and systematic review that yielded several candidate-
synthesized documents that could serve as the eviden-
tiary base for these guideline recommendations. Three
systematic reviews [10-12], published in a 2008 special
issue of the American Journal of Preventive Medicine,
were chosen because of their direct relevance to the
project objectives, their currency, and their quality.
These were accompanied by recommendations from the
United States (US) Task Force on Community Preven-
tive Services [13].
A two-stage update process of the systematic reviews
was undertaken by the expert panel to identify new eli-
gible studies published between 2004 and May 2010.
Quality appraisal of the new studies was untaken. Com-
plete methodological details and results of the systema-
tic reviews can be found elsewhere [14,15].
Together with the evidence from the original reviews
[10-12], the expert panel considered the studies over
several meetings and came to a consensus on a set of
guideline recommendations,s u g g e s t i o n sf o rh o wt h e
recommendations could be used, and ideas for future
research priorities. The panel considered issues of data
quantity, data quality, and the Ontario context when
interpreting and judging the evidence. A decision rubric
was developed by the panel, informed by the original
reports, in order to have a common language by which
the recommendations could be classified. In cases where
there was an absence of evidence, the conclusion of the
panel was that there was no evidence to refute or sup-
port the particular intervention; in cases where the evi-
dence was not compelling, the conclusion was that there
was insufficient evidence; in cases where the evidence
was compelling, as deemed by the panel, the conclusion
was to recommend the intervention. This strategy aligns
conceptually with the original reports [10-12]. Consen-
sus was reached by all members of the panel in both the
interpretation and classification of recommendations,
and no formal consensus method (e.g., Delphi techni-
que) were used.
Subsequently, a two-step review strategy was underta-
ken. First, a draft document was circulated to Cancer
Care Ontario’s Report Approval Panel (RAP). It is com-
prised of clinicians, screening experts, and methodolo-
gists. Their role was review the draft document with
special attention to methodological quality, provide feed-
back, and ultimately approve the document for circula-
tion to the external reviewer pool.
The revised and approved draft document was then
circulated to eight Canadian and American external
reviewers with expertise in the clinical and methodolo-
gical aspects of cancer screening and guideline devel-
opment. They were asked to complete questionnaire
using a five-point scale targeting the quality of guide-
line (higher scores indicating better quality) and their
intention to use a guideline of this quality (higher
scores indicating greater intention). Specifically, these
stakeholders rated the guideline development methods,
guideline presentation, guideline recommendations,
completeness of recommendations, whether there was
sufficient information to inform decisions, overall
guideline quality, the likelihood they would make use
of this guideline in professional decisions, and in their
practice. Note that the psychometric properties of this
q u e s t i o n n a i r eh a v en o tb e e nf u l l yt e s t e d .T h ee x p e r t
panel took this feedback and made revisions before the
final document was released to Cancer Care Ontario
[14].
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Results
Evidentiary base
An additional 66 randomized controlled trials (RCTs)
and cluster randomized trials reflecting 74 comparisons
were found that met inclusion criteria. Overall, the qual-
ity of the trials ranged considerably, but was generally
weak. Full details on the results of the updates can be
found elsewhere [14]. Thus, three foundational systema-
tic reviews [10-12], additional trial data [16-89] and the
original recommendations of the US Task Force [13]
served as the evidentiary foundation to inform the
guideline recommendations reported here. A draft prac-
tice guideline document was crafted. The first section
consisted of the guideline questions, statement of the
intended users, overview of the key evidence, draft
recommendations, qualifying statements, advice on how
to use the recommendations, and research priorities.
Draft guideline review
The RAP review of the draft guideline document yielded
favourable feedback for the expert panel. Key modifica-
tions included strengthening the section on how the
guidance should be used and being more explicit about
some the challenges inherent the implementation
science literature. With respect the external review pro-
cess, feedback was received from five reviewers. Mean
ratings were favourable across all indices: quality of
methods (4.8), guideline presentation (4.6), quality of
recommendations (4.2), completeness of reporting (4.8),
sufficient information to inform decisions (4.2), overall
quality (4.6), intention to use (4.8), and willingness to
recommend for use in practice (5.0) (range 1 to 5; 5
most favourable score). Reviewers provided suggestions
for how the recommendations could be implemented.
Final revisions to the guideline were made.
Recommendations
Table 1 summarizes the recommendations of the Cancer
Screening Uptake Expert Panel regarding population-
based interventions to increase the demand for cancer
screening, population-based interventions to reduce bar-
riers to obtaining screening, and provider-directed inter-
ventions targeted at clinicians to implement in the
primary care setting.
Specific recommendations
1. Client reminders and small media are effective popu-
lation-based interventions to increase the uptake of
breast, cervical, and CRC screening.
2. One-on-one education is an effective population-
based intervention to increase the uptake of breast and
cervical cancer screening. Evidence is emerging suggest-
ing one-on-one education might facilitate the uptake of
CRC screening, and should be considered as an option
in the context of CRC screening.
3. Reducing structural barriers is an effective interven-
tion to increase community access and reduce barriers
Table 1 Summary of recommendations of cancer care Ontario’s Cancer Screening Uptake Expert Panel for breast,
cervical and colorectal cancer screening
Population-based interventions to increase demand for screening References
Intervention Breast Cervical Colorectal
Client reminders Recommended [16-33]
Client incentives alone There is insufficient evidence to recommend for or against this intervention.
Mass media alone There is insufficient evidence to recommend for or against this intervention. [34-56]
Small media Recommended
Group education There is insufficient evidence to recommend for or against this intervention. [57-74]
One-on-one education Recommended Recommended Consider
Population-based interventions to reduce barriers to obtaining screening References
Intervention Breast Cervical Colorectal
Reducing structural barriers Recommended Recommended There is insufficient
evidence to recommend for
or against this intervention.
[75-80]
Reducing out-of-pocket costs There is insufficient evidence to recommend for or against this intervention for the Ontario
context.
Interventions directed at healthcare providers to increase screening References
Interventions Breast Cervical Colorectal [81-89]
Provider assessment and feedback Recommended
Provider incentives There is insufficient evidence to recommend for or against this intervention.
Note: Recommendation table template designed by the United States (US) Task Force on Community Preventive Services [13].
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cient evidence to support or refute its role in CRC
screening.
4. Provider assessment and feedback is an effective
provider-focused intervention to increase the uptake of
breast, cervical, and CRC screening.
5. At this time, there is insufficient evidence to sup-
port or refute the role of client incentives, mass media,
group education, reducing out-of-pocket costs, and pro-
vider incentives as strategies to increase the uptake of
breast, cervical, or CRC screening.
6. There are no interventions studied in this review
that led the Cancer Screening Uptake Expert Panel to
recommend unequivocally against their use because of
proven ineffectiveness.
With few exceptions, the recommendations of the
Cancer Screening Uptake Expert Panel align with the
original recommendations of the US Task Force. The
exceptions include:
1. The expert panel chose not to categorize the
strength of the recommendations or evidence founda-
tion due to the inability to form reliable operational
definitions that could be consistently applied across the
areas of inquiry.
2. The expert panel believes the new evidence emerging
in the update is sufficient to reclassify one-on-one educa-
tion for CRC from the original ‘not recommend’ to ‘con-
sider’ as an option. The ‘consider’ category emerged post
hoc after the initial decision rubric was developed.
3. The expert panel did not view the evidence
regarding reducing out-of-pocket costs for patients as
relevant to the publicly-funded Ontario context and
could not recommend for or against that intervention.
This may be pertinent to similar contexts in which
screening is offered. Covering patient expenditures
associated with screening, for example, parking, or
colonoscopy preparation material costs are additional
strategies worthy of study that may remove barriers
that prevent a patient obtaining a screening procedure.
Privately-funded systems may interpret these data dif-
ferently for their context and arrive at different
recommendations.
Qualifying statements
Recommendation caveats
1 .T h e r ei sl i t t l ee v i d e n c ed i r e c t l yt e s t i n gt h ee f f e c t i v e -
ness of interventions for different populations; nonethe-
less, subgroup analysis suggests group education may be
a useful intervention for special populations such as spe-
cific ethnic groups or other groups for whom access to
healthcare might be challenging.
2. There is little evidence directly testing the effective-
ness of interventions for different provider groups;
nonetheless, evidence suggests that provider assessment
and feedback may be more effective for trainees than for
established practitioners.
3. Types of provider incentives explored in the original
systematic review and the updated studies may or may
not be generalizable across healthcare contexts. For
example, currently in Ontario, there are some financial
incentive strategies (for example, fee codes and bonus
payments) for screening that should be explored and
evaluated more thoroughly.
4. Across the studies, the labelling, categorization, and
operationalization of several of the interventions evalu-
ated were inconsistent and overlapping. This precludes
recommendations for specific options within the suite of
activities the intervention represents. Nonetheless, it is
important to the note that across categories where the
greatest overlap exists (i.e., client reminders, small
media, and one-on-one education) the evidence is gen-
erally consistent and in favour of the interventions.
5. The methods by which information was tailored
varied across studies. As such, no specific advice can be
offered in favour of one tailoring strategy over another.
6. The literature is incomplete in differentiating
between newly screened and repeat-screened individuals.
This precludes making recommendations for each of
these population groups.
7. There are several screening options within each
cancer site, particularly in the case of CRC screening
(fecal occult blood test (FOBT), flexible sigmoidoscopy
(FS), and colonoscopy). Studies varied in terms of the
types of screening covered, and in no case was an analy-
sis of a specific modality complete. This precludes mak-
ing specific recommendations for each screening
modality within that disease site.
Methodological caveats
1. In contrast to the original systematic reviews that
included a range of study designs, the update of the lit-
erature focused on RCTs and cluster RCTs only.
2. The quality of RCTs and cluster RCTs in the
update was poor, primarily due to the incomplete
reporting of quality characteristics information in the
studies.
3. Measures of the key outcome, percentage point (PP)
change, were calculated in the original systematic
reviews and the update using various strategies based on
the availability of the data. While larger PP changes are
more indicative of greater effectiveness, the absolute
magnitude of effect cannot be calculated, and compari-
sons across studies using different data may be
misleading.
Resources caveat
An update and review of the cost-effectiveness data ana-
lysis fell outside the scope of our guideline due to lim-
ited resources to conduct more systematic and high
quality cost-effectiveness analyses and the interpretation
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could be reliably generalized to other contexts. None-
theless, appropriate planning and resource estimates
should be considered before the implementation of an
intervention.
How to apply the recommendations
The recommendations provide information regarding
what suites of interventions are more or less effective at
increasing the uptake of cancer screening. The recom-
mendations do not provide specific advice regarding
which activity or elements within that intervention
g r o u ps h o u l db ei m p l e m e n t e do rf o rw h i c hs p e c i f i c
populations or providers one might see the greatest
effect. To make these decisions, users are encouraged to
do the following:
1. Choose a few candidate studies with populations,
p r o v i d e r s ,a n dc o n t e x t st h a tm o s tc l o s e l ya l i g nw i t h
your own populations, providers, and context.
a. This can be accomplished by reviewing study
details presented in the text and tables in the sys-
tematic reviews [14,15].
b. Recognize that there is significant overlap across
some of the intervention categories that show the
greatest promise (e.g., client reminders, one-on-one
education, and small media), and consider this when
developing your own suite of interventions.
2. Consider and deliberate:
a. Which activities and operational details have the
greatest face validity for your context?
b. Would these activities be acceptable to the popu-
lations you are targeting?
c. Do you have the resources (e.g., human, financial)
to offer these interventions?
d. Do you have the capacity to measure their
impact?
3. Contribute to the knowledge base.
4. Where possible, build into your activities a formal,
high-quality evaluation strategy and communicate your
findings to a wider audience, including the scientific
community. These data can be used to improve the
knowledge base and enable health services researchers
to refine what is known and provide more precise
recommendations in the future.
Potential research areas
The evidence review identified several potential research
areas that could advance the knowledge in this area.
Some of these include:
1. Research targeting interventions that provide insuffi-
cient information to conclude for or against effectiveness.
This includes client incentives, mass media, group
education, reducing out-of-pocket costs (relevant specific
contexts), and provider incentives as strategies to
increase the uptake of breast, cervical, or CRC screening.
2. Research to disentangle the multiple operational
elements that define the various interventions to test
those that are more and less effective, and further, to
explain whether the cumulative impact of these inter-
ventions can facilitate achieving the desired behavioural
outcomes
3. Research specifically designed to study the effects of
interventions across different populations. Repeat-
screened versus never-been-screened populations, gen-
eral populations versus specific ethnic groups, and other
groups for whom access to healthcare might be more
challenging are of particular interest.
4. Research to determine more accurately the efficacy
of tailored versus non-tailored approaches, including the
cost-effectiveness of more complex tailored approaches.
5. Research to analyze and evaluate the cost-effective-
ness of specific interventions using strategies that will
yield data relevant to the specific contexts where screen-
ing is offered.
6. Research to investigate the impact of more recent
electronic and other mass media interventions when tar-
geting either general or specific populations.
7. Research to compare the impact of interventions
related to the type of healthcare practitioner delivering
that intervention (e.g., family physician, nurse practi-
tioner, pharmacist).
Conclusion
While the guideline was developed within the Ontario
(Canada) context, we believe the evidence updates and
recommendations provide a valuable source of informa-
tion to clinicians, policy makers, and researchers inter-
nationally who have an interest and mandate to advance
quality of cancer control and, in particular, cancer
screening. However, we acknowledge that recommenda-
tions may vary from jurisdiction to jurisdiction due to
the unique system, funding, and contextual structures
that may influence the interpretation of evidence and its
application [14]. Guideline developers are encouraged to
consider formal guideline adaptation strategies in using
the systematic review and guideline as a foundation for
their own goals (see http://www.cancerview.ca/portal/
server.pt/community/tools_and_resources/519/guideli-
ne_adaptation/5627) [90].
Our methodology did not include representatives from
patient groups and the public. We acknowledge this as
limitation. While in the Ontario system the approach is
to focus on alternative avenues for engagement of these
stakeholders (e.g., by regional health networks, imple-
mentation committees) these perspectives at the guide-
line development level would be an asset [91].
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progress on the research front has been made, further
investigation is required and, more importantly, efforts
to better direct how research findings can be put into
practice are warranted. The panel puts forward sugges-
tions for how best to use the guideline recommenda-
tions and areas we saw as future research priorities.
Continued advancement in this field are required if the
full benefits of cancer screening and their impact on
public and patient health will be realized.
Additional material
Additional file 1: Appendix 1. Expert panel members. Appendix 1.
Members of Cancer Screening Uptake Expert Panel.
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